RESEARCH ＆ DEVELOPMENT
Indications Under Development
Back to previous
Innovation With Speed
Reistone is focused on rapidly developing innovative medicines through global
collaborations within Research and Development
Patient Need Is Our Passion
Research & Development
At Reistone we devised our clinical development strategy around three key pillars: Science, People and Process. These key pillars serve as our guiding principles in clinical development.
2020/07/13 —— Reistone Biopharma Appoints Dr. Qais Mekki as Senior Vice President, Head of International Development, US Site Head
2020/06/19 —— Reistone Announces First Patient Dosed in a Phase II Global Study of SHR0302 JAK Inhibitor for Alopecia Areata
2019/11/12 —— Irwin Wang – CEO, Reistone Biopharma, China
Partnership is core to our business model. We are committed to partnering with R&D based global pharma and biotech companies to bring innovative medicines to patients.
People represent our key success pillar. We are keen to recruit new talent into Reistone where you can develop and achieve your career aspirations.
Shanghai (Headquarter), China
203,2F，Xiangke Road，Zhangjiang Hi-Tech Park，Pudong，
ZIP code: 201210
101, 3F Air China Century Building, No.40 Xiaoyun Rd,
Chaoyang District Beijing, China. 100027
1 Lincoln Street, 29
Boston, MA 02111, USA